Targeting the tumor vascular compartment to improve conventional cancer therapy
about
Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applicationsMicrobubble and ultrasound radioenhancement of bladder cancer.Potential role of vascular targeted therapy to combat against tumor.Tumor-penetrating peptides.MT-MMPS as Regulators of Vessel Stability Associated with AngiogenesisSynthesis of 2-anilinopyridyl-triazole conjugates as antimitotic agents.Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy.High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profileTransport and peripheral bioactivities of nitrogen oxides carried by red blood cell hemoglobin: role in oxygen delivery.Nanovehicular intracellular delivery systems.Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours.Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical modelTargeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.Tumor-penetrating peptides: a shift from magic bullets to magic guns.Helical peptides from VEGF and Vammin hotspots for modulating the VEGF-VEGFR interaction.
P2860
Q28081554-962EC936-574B-44C2-BEAE-71674501884FQ30451819-FABF75CD-49C2-4CA7-8F0D-0EA08FC66618Q33470615-9B93C86C-69F6-4BB1-B951-29323202CDF8Q34976054-D7E3E958-64D5-4CCC-A241-32018821D12EQ35025845-478AE9B3-2672-4FD6-BD2B-99AA62DB086DQ35576061-70EFD90D-EBE6-49CE-9580-8679C3F76128Q35975832-0CD9DE08-A5B0-4058-9E2E-EE59C84F0E22Q36609613-710B5E8E-AF0E-4F70-A081-3C74EF9430A6Q36786247-7B839F94-0B03-4ED7-9202-5C8EF3BA0E0EQ37058812-76661A83-6E3E-4DF4-90BE-8F3CE7E2C7EBQ37323077-B7D60706-30D3-4843-B4E6-C645599CAB63Q37628695-2614BFF4-54AA-4B4B-B120-755331DD4651Q37846342-6A463BE8-CD69-4CBE-A112-9E4C961B5100Q39312575-C283C630-9944-4C85-84DB-FEF6182D897BQ39497343-B52B6B44-8C68-426C-BF29-96D1F6D56712Q43046012-7A9BBD0C-A38A-4A7A-BEB4-B80E08EA1A2FQ46819215-686792C2-0527-440C-9F10-2AA69B624D41
P2860
Targeting the tumor vascular compartment to improve conventional cancer therapy
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Targeting the tumor vascular compartment to improve conventional cancer therapy
@ast
Targeting the tumor vascular compartment to improve conventional cancer therapy
@en
Targeting the tumor vascular compartment to improve conventional cancer therapy
@nl
type
label
Targeting the tumor vascular compartment to improve conventional cancer therapy
@ast
Targeting the tumor vascular compartment to improve conventional cancer therapy
@en
Targeting the tumor vascular compartment to improve conventional cancer therapy
@nl
prefLabel
Targeting the tumor vascular compartment to improve conventional cancer therapy
@ast
Targeting the tumor vascular compartment to improve conventional cancer therapy
@en
Targeting the tumor vascular compartment to improve conventional cancer therapy
@nl
P1476
Targeting the tumor vascular compartment to improve conventional cancer therapy
@en
P2093
Olivier Feron
P304
P356
10.1016/J.TIPS.2004.08.008
P407
P577
2004-10-01T00:00:00Z